The estimated Net Worth of Michelle Graham is at least $1.18 Millón dollars as of 23 January 2023. Ms. Graham owns over 102 units of Albireo Pharma Inc stock worth over $1,081,366 and over the last 8 years she sold ALBO stock worth over $100,721. In addition, she makes $0 as Chief Human Resource Officer at Albireo Pharma Inc.
Sign up
Ms. Graham ALBO stock SEC Form 4 insiders trading
Michelle has made over 6 trades of the Albireo Pharma Inc stock since 2022, according to the Form 4 filled with the SEC. Most recently she sold 102 units of ALBO stock worth $4,468 on 23 January 2023.
The largest trade she's ever made was selling 1,774 units of Albireo Pharma Inc stock on 19 January 2023 worth over $77,879. On average, Michelle trades about 137 units every 19 days since 2016. As of 23 January 2023 she still owns at least 24,493 units of Albireo Pharma Inc stock.
You can see the complete history of Ms. Graham stock trades at the bottom of the page.
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Wallmine is a radically better financial terminal.
Sign up in seconds, it's free!
Michelle Graham biography
Michelle C. Graham is appointed as Chief Human Resource Officer of the Company. She previously served as Senior Vice President and Chief Human Resources Officer at TESARO, Inc. from March 2018 to July 2019. In that role, she participated in strategic planning to scale the company, while maintaining a strong corporate culture. Prior to that, from January 2015 to January 2018, she served as Senior Vice President and Chief Human Resources Officer at Parexel International Corporation, a pharmaceutical services company. Earlier in her career, she held senior human resources and organizational development leadership positions in the health and medicine industries, including at Integer, Bausch + Lomb and Bristol-Myers Squibb. Ms. Graham holds a bachelor's degree in Business Administration and Management and a master's degree in Labor and Industrial Relations from Michigan State University.
How old is Michelle Graham?
Michelle Graham is 53, she's been the Chief Human Resource Officer of Albireo Pharma Inc since 2019. There are 16 older and 3 younger executives at Albireo Pharma Inc. The oldest executive at Albireo Pharma Inc is Davey Scoon, 73, who is the Independent Director.
What's Michelle Graham's mailing address?
Michelle's mailing address filed with the SEC is C/O ALBIREO PHARMA, INC., 53 STATE STREET, 19TH FLOOR, BOSTON, MA, 02109.
Insiders trading at Albireo Pharma Inc
Over the last 8 years, insiders at Albireo Pharma Inc have traded over $26,339,822 worth of Albireo Pharma Inc stock and bought 932,623 units worth $30,497,757 . The most active insiders traders include Advisors Llcperceptive Life..., Roger Jeffs y Plcastrazeneca Ab Astrazeneca. On average, Albireo Pharma Inc executives and independent directors trade stock every 19 days with the average trade being worth of $957,260. The most recent stock trade was executed by Pamela Stephenson on 23 January 2023, trading 102 units of ALBO stock currently worth $4,468.
What does Albireo Pharma Inc do?
Albireo Pharma is a clinical-stage biopharmaceutical company focused on the development of novel bile acid modulators to treat rare pediatric and adult liver diseases, and other adult liver diseases and disorders. Albireo's lead product candidate, odevixibat, is being developed to treat rare pediatric cholestatic liver diseases with Phase 3 pivotal trials in PFIC, Alagille syndrome and biliary atresia. The Company completed IND-enabling studies for new preclinical candidate A3907 this year and plans to advance development in adult liver disease. Albireo was spun out from AstraZeneca in 2008 and is headquartered in Boston, Massachusetts, with its key operating subsidiary in Gothenburg, Sweden. The Boston Business Journal named Albireo one of the 2020 Best Places to Work in Massachusetts for the second consecutive year.
What does Albireo Pharma Inc's logo look like?
Complete history of Ms. Graham stock trades at Albireo Pharma Inc
Albireo Pharma Inc executives and stock owners
Albireo Pharma Inc executives and other stock owners filed with the SEC include:
-
Ronald Cooper,
President, Chief Executive Officer, Director -
Pamela Stephenson,
Chief Commercial Officer -
Jan Mattsson,
Chief Scientific Officer -
Martha Carter,
Chief Regulatory Officer -
Ronald H. W. Cooper,
CEO, Pres & Director -
Patrick Horn,
Chief Medical Officer -
Martha J. Carter,
Chief Regulatory Officer -
Simon Nicolas Reade Harford,
CFO & Treasurer -
David Chiswell,
Independent Chairman of the Board -
Davey Scoon,
Independent Director -
Michael Gutch,
Independent Director -
Roger Jeffs,
Independent Director -
Stephanie Okey,
Independent Director -
Anne Klibanski,
Independent Director -
Jason Duncan,
Chief Legal Officer, General Counsel, Secretary -
Michelle Graham,
Chief Human Resource Officer -
Simon Harford,
Chief Financial Officer, Treasurer -
Jason G. Duncan,
Chief Legal Officer, Gen. Counsel & Sec. -
Pamela Stephenson M.P.H.,
Chief Commercial Officer -
Dr. Kristina Torfgard,
VP & Global Project Head -
Michelle Graham,
Chief HR Officer -
Joan Connolly,
Chief Technology Officer -
Dr. Jan P. Mattsson Ph.D.,
Chief Scientific Officer, MD (Sweden) & Co-Founder -
Dr. Per-Goran Gillberg,
Co-Founder & VP of Devel. -
Denise Scots Knight,
Director -
Julia R Brown,
Director -
Heather Preston,
Director -
Paresh Soni,
Chief Medical Officer -
Thomas A. Shea,
CFO and Treasurer -
Peter A Zorn,
Senior VP, Corp Dev, GC & Sec -
Plcastrazeneca Ab Astrazeneca,
-
Paul Streck,
Chief Medical Officer -
Advisors Llcperceptive Life...,
-
Partners Ltd Phase4 Venture...,
-
Craig C. Hopkinson,
Director -
Susan Alesina,
Director -
Habib J Dable,
Director